Beta-sitosterol for Subarachnoid Hemorrhage: Mechanistic Analysis of Recovery and Therapy

Exclusion Criteria

• •Non-aneurysmal SAH (e.g., caused by trauma, arteriovenous malformation, etc.).
• •Secondary to other severe intracranial diseases (e.g., large intracerebral hematoma, severe brain herniation).
• •Complicated with severe cardiac, hepatic, renal, or hematopoietic system dysfunction (as defined by specific laboratory criteria).
• •Known allergy to Gastrodia elata or any of its components.
• •Pregnancy or breastfeeding.
• •Participation in another interventional clinical trial within 30 days prior to enrollment.
• •Any other condition that, in the judgment of the investigator, makes the patient unsuitable for participation in this study.